• SENSEX
    NIFTY 50
Healthcare

Cadila announces completion of Phase I clinical trial of ZyCoV-D; Phase II from Aug 6

Updated : August 05, 2020 01:07 PM IST

The company will now commence Phase II clinical trials from August 6.
The vaccine was able to elicit high level of neutralizing antibodies in animal studies, Cadila Healthcare said.
Cadila announces completion of Phase I clinical trial of ZyCoV-D; Phase II from Aug 6

You May Also Like

Live TV

recommended for you

Advertisement